Yervoy 200 MG/40 ML vial 40ML
Ended Awarded
- Contract number
- SPE2DB26FX4EH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,958
Award facts
- Contract value 100% obligated
- $22,957.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $22,957.99 to AmerisourceBergen Drug Corp for the supply of Yervoy 200 mg/40 ml vials on October 31, 2025, with an ultimate completion date of November 24, 2025. This non-competitive, firm fixed-price delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999.999 billion through December 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs.
Yervoy (ipilimumab) is an immunotherapy medication used to treat certain types of cancer. This delivery order exemplifies AmerisourceBergen's critical role in the federal medical supply chain, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver specialized pharmaceutical products across multiple therapeutic domains through competitive acquisition processes. As a prime vendor under the DLA's comprehensive pharmaceutical support vehicle, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with the DLA planning to expand its Pharmaceutical Prime Vendor Global Program Generation V contracts to include multiple regional awards.
Quick answers
Who was awarded contract SPE2DB26FX4EH?
SPE2DB26FX4EH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DB26FX4EH worth?
The government has obligated $22,958 on SPE2DB26FX4EH.
Is contract SPE2DB26FX4EH an order under another contract?
Yes. SPE2DB26FX4EH is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB26FX4EH competed?
The extent of competition for SPE2DB26FX4EH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award